Most Wall Street analysts carry a consensus price target of just $3.42, with 8 of 12 analysts rating the stock a Hold.

Goldman Sachs is taking a more assertive stance with a $3.95 price target while maintaining its Buy rating.

To get there, Petco will have to return to positive comparable sales as guided, continue EBITDA margin expansion and see stabilization in the broader consumer environment.

The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE.

Petco Health & Wellness (NASDAQ:WOOF) has surged nearly 48% over the past week and 37% over the past month, with shares now trading around $3.44 as of March 13. Year-to-date the stock is up more than 20%, though it remains well below its 52-week high of $4.50.

Most Wall Street analysts carry a consensus price target of just $3.42, with 8 of 12 analysts rating the stock a Hold. But Goldman Sachs is taking a more assertive stance. The firm maintained a Buy rating and issued a $3.95 price target (lowered from $4.53), representing meaningful upside from the March 11 filing price of $2.53. But can WOOF realistically reach $3.95 by the end of 2026?

READ: The analyst who called NVIDIA in 2010 just named his top 10 AI stocks

Goldman's conviction rests on Petco's Q4 adjusted EBITDA of $106.29M, which came in above both company guidance and consensus estimates. Adjusted EBITDA margin expanded to 7.0% from 6.2% a year ago, signaling that management's cost restructuring is translating into durable profitability gains rather than one-time improvements. The firm views this as evidence that the operational reset under CEO Joel Anderson is on track.

EBITDA beat and margin expansion: Q4 adjusted EBITDA rose 10.6% year-over-year with margin improvement of 80 basis points to 7.0%. Q4 adjusted EBITDA rose 10.6% year-over-year with margin improvement of 80 basis points to 7.0%.

Better-than-guided profitability: Full-year FY2026 adjusted EBITDA guidance of $415M-$430M reflects management's confidence in sustaining gains. Free cash flow nearly doubled year-over-year to $186.953M for the full year, providing a buffer to service debt and reinvest without diluting shareholders.

Improving operational execution: The leverage ratio improved sharply from 4.2x to 3.0x, reducing financial risk. Cash on the balance sheet grew 54.89% year-over-year to $256.736M, giving Petco flexibility that was absent just a year ago.

At 243.453 million shares outstanding, a $3.95 price target represents meaningful upside from the current price. Getting there requires three things: a return to positive comparable sales as guided, continued EBITDA margin expansion toward the $415M-$430M target range, and stabilization in the broader consumer environment. University of Michigan consumer sentiment sits at a pessimistic 56.4, so Petco's comp recovery thesis depends on sentiment improvement that is not yet confirmed.

The primary risk is tariff uncertainty, which management explicitly flagged as an assumption embedded in guidance. Still, with free cash flow accelerating, leverage declining, and EBITDA beating expectations, Goldman's $3.95 target reflects a credible path if operational improvements continue.

Wall Street is pouring billions into AI, but most investors are buying the wrong stocks. The analyst who first identified NVIDIA as a buy back in 2010 โ€” before its 28,000% run โ€” has just pinpointed 10 new AI companies he believes could deliver outsized returns from here. One dominates a $100 billion equipment market. Another is solving the single biggest bottleneck holding back AI data centers. A third is a pure-play on an optical networking market set to quadruple. Most investors haven't heard of half these names. Get the free list of all 10 stocks here.